BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gong Q, Gregg EW, Wang J, An Y, Zhang P, Yang W, Li H, Li H, Jiang Y, Shuai Y. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study. Diabetologia. 2011;54:300-307. [PMID: 21046360 DOI: 10.1007/s00125-010-1948-9] [Cited by in Crossref: 151] [Cited by in F6Publishing: 134] [Article Influence: 12.6] [Reference Citation Analysis]
Number Citing Articles
1 Wang Q, Zeng N, Tang H, Yang X, Yao Q, Zhang L, Zhang H, Zhang Y, Nie X, Liao X, Jiang F. Diabetic retinopathy risk prediction in patients with type 2 diabetes mellitus using a nomogram model. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.993423] [Reference Citation Analysis]
2 Bouclaous C, Azar LJ, Barmo N, Daher R, Tabaja J, El Hout G, Berika L. Levels and Correlates of Numeracy Skills in Lebanese Adults with Diabetes: A Cross-Sectional Study. IJERPH 2022;19:10557. [DOI: 10.3390/ijerph191710557] [Reference Citation Analysis]
3 Gu M, Lin Y, Gai X, Wei X, Lu C, Wang Y, Ding X, Peng Y, Ma Y. High Serum FABP4 Levels are Negatively Associated with the Reversion from Prediabetes to Normal Glucose Tolerance: A 2-Year Retrospective Cohort Community Study. DMSO 2022;Volume 15:2217-25. [DOI: 10.2147/dmso.s374912] [Reference Citation Analysis]
4 Carvajal-Moreno L, Coheña-Jiménez M, García-Ventura I, Pabón-Carrasco M, Pérez-Belloso AJ. Prevention of Peripheral Distal Polyneuropathy in Patients with Diabetes: A Systematic Review. J Clin Med 2022;11:1723. [PMID: 35330052 DOI: 10.3390/jcm11061723] [Reference Citation Analysis]
5 Zhou R, Cui Y, Zhang Y, De J, An X, Duan Y, Zhang Y, Kang X, Lian F. The Long-Term Effects of Non-Pharmacological Interventions on Diabetes and Chronic Complication Outcomes in Patients With Hyperglycemia: A Systematic Review and Meta-Analysis. Front Endocrinol 2022;13:838224. [DOI: 10.3389/fendo.2022.838224] [Reference Citation Analysis]
6 Li N, Lu C, Ma Y, Wang X, Ling Y, Yin Y, Li S, Huang J, Yu L, Dong W, He H, Kang M, Ma L, Gu M, Zhao L, Huang Y, Liu F, Wang Y, Gai X, Jiang J, Peng Y, Ding X. Factors Associated with Progression of Different Prediabetic Status to Diabetes: A Community-based Cohort Study. Diabetes Res Clin Pract 2022;:109193. [PMID: 35032561 DOI: 10.1016/j.diabres.2022.109193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zilliox LA, Chandrasekaran K, Russell JW. Strategies for the prevention or reversal of neuropathy. Diabetic Neuropathy 2022. [DOI: 10.1016/b978-0-12-820669-0.00016-5] [Reference Citation Analysis]
8 刘 丽. Current Situation and New Progress of the Prevention and Treatment of Diabetic Macular Oedema. MD 2022;12:72-83. [DOI: 10.12677/md.2022.121012] [Reference Citation Analysis]
9 Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, Prahalad P, Reusch JEB, Young-Hyman D, Das S, Kosiborod M; American Diabetes Association Professional Practice Committee., American Diabetes Association Professional Practice Committee:. 3. Prevention or Delay of Type 2 Diabetes and Associated Comorbidities: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45:S39-45. [PMID: 34964876 DOI: 10.2337/dc22-S003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 21] [Article Influence: 14.0] [Reference Citation Analysis]
10 Wei S, Brejnrod AD, Trivedi U, Mortensen MS, Johansen MY, Karstoft K, Vaag AA, Ried-Larsen M, Sørensen SJ. Impact of intensive lifestyle intervention on gut microbiota composition in type 2 diabetes: a post-hoc analysis of a randomized clinical trial. Gut Microbes 2022;14:2005407. [PMID: 34965188 DOI: 10.1080/19490976.2021.2005407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Echouffo-Tcheugui JB, Selvin E. Prediabetes and What It Means: The Epidemiological Evidence. Annu Rev Public Health 2021;42:59-77. [PMID: 33355476 DOI: 10.1146/annurev-publhealth-090419-102644] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 24.0] [Reference Citation Analysis]
12 Khaltaev N, Axelrod S. Global trends in diabetes-related mortality with regard to lifestyle modifications, risk factors, and affordable management: A preliminary analysis. Chronic Dis Transl Med 2021;7:182-9. [PMID: 34505018 DOI: 10.1016/j.cdtm.2021.03.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Gong Q, Zhang P, Wang J, Gregg EW, Cheng YJ, Li G, Bennett PH; Da Qing Diabetes Prevention Outcome Study Group. Efficacy of lifestyle intervention in adults with impaired glucose tolerance with and without impaired fasting plasma glucose: A post hoc analysis of Da Qing Diabetes Prevention Outcome Study. Diabetes Obes Metab 2021;23:2385-94. [PMID: 34212465 DOI: 10.1111/dom.14481] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Shen CB, Qian X, Yu RX, Ji XL, Shi YJ, Gao J, Li CX, Li KK, Fei WM, Shen X, Wang ZY, Han Y, Ning XL, Ko R, Hsu YH, Yin XY, Li GW, Cui Y. Skin diseases in the Da Qing Diabetes Study: a cross-sectional study. Chin Med J (Engl) 2021;134:1191-8. [PMID: 34018997 DOI: 10.1097/CM9.0000000000001453] [Reference Citation Analysis]
15 Zhu C, Zhu J, Wang L, Xiong S, Zou Y, Huang J, Xie H, Zhang W, Wu H, Liu Y. Development and Validation of a Risk Prediction Model for Diabetic Retinopathy in Type 2 Diabetic Patients (Preprint).. [DOI: 10.2196/preprints.29078] [Reference Citation Analysis]
16 Kheniser K, Saxon DR, Kashyap SR. Long-Term Weight Loss Strategies for Obesity. J Clin Endocrinol Metab 2021;106:1854-66. [PMID: 33595666 DOI: 10.1210/clinem/dgab091] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
17 Savelieff MG, Callaghan BC, Feldman EL. The emerging role of dyslipidemia in diabetic microvascular complications. Curr Opin Endocrinol Diabetes Obes 2020;27:115-23. [PMID: 32073426 DOI: 10.1097/MED.0000000000000533] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 12.5] [Reference Citation Analysis]
18 Yau JW, Thor SM, Ramadas A. Nutritional Strategies in Prediabetes: A Scoping Review of Recent Evidence. Nutrients 2020;12:E2990. [PMID: 33003593 DOI: 10.3390/nu12102990] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
19 Alateeq MA, Aljohani M, Kinani SS, Aljabr IA, Alduayji AA, Aloud A, Alzahrani E, Alharbi K. The Prediabetes Outcome at National Guard Primary Health Care Centers in Riyadh, Saudi Arabia: Retrospective Chart Review. Cureus 2020;12:e10227. [PMID: 33042670 DOI: 10.7759/cureus.10227] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Nishi H, Takemura K, Higashihara T, Inagi R. Uremic Sarcopenia: Clinical Evidence and Basic Experimental Approach. Nutrients 2020;12:E1814. [PMID: 32570738 DOI: 10.3390/nu12061814] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
21 Han Y, Zhang S, Chen S, Zhang J, Guo X, Yang X. Incidence and risk factors of type 2 diabetes mellitus in individuals with different fasting plasma glucose levels. Ther Adv Endocrinol Metab 2020;11:2042018820928844. [PMID: 32577198 DOI: 10.1177/2042018820928844] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Heisler M, Kullgren J, Richardson C, Stoll S, Alvarado Nieves C, Wiley D, Sedgwick T, Adams A, Hedderson M, Kim E, Rao M, Schmittdiel JA. Study protocol: Using peer support to aid in prevention and treatment in prediabetes (UPSTART). Contemp Clin Trials 2020;95:106048. [PMID: 32497783 DOI: 10.1016/j.cct.2020.106048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Ho M, Chau PH, Yu EYT, Ying MT, Lam CLK. Community-based weight loss programme targeting overweight Chinese adults with pre-diabetes: study protocol of a randomised controlled trial. BMJ Open 2020;10:e035196. [PMID: 32273317 DOI: 10.1136/bmjopen-2019-035196] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Sallar A, Dagogo-Jack S. Regression from prediabetes to normal glucose regulation: State of the science. Exp Biol Med (Maywood) 2020;245:889-96. [PMID: 32212859 DOI: 10.1177/1535370220915644] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
25 Haines M. Feasibility of procedures for a randomised pilot study of reduced exertion, high-intensity interval training (REHIT) with non-diabetic hyperglycaemia patients. Pilot Feasibility Stud 2020;6:28. [PMID: 32099663 DOI: 10.1186/s40814-020-00571-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
26 Herrick CJ, Puri R, Rahaman R, Hardi A, Stewart K, Colditz GA. Maternal Race/Ethnicity and Postpartum Diabetes Screening: A Systematic Review and Meta-Analysis. J Womens Health (Larchmt) 2020;29:609-21. [PMID: 32074479 DOI: 10.1089/jwh.2019.8081] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
27 Parrizas M, Mundet X, Castaño C, Canivell S, Cos X, Brugnara L, Giráldez-García C, Regidor E, Mata-Cases M, Franch-Nadal J, Novials A. miR-10b and miR-223-3p in serum microvesicles signal progression from prediabetes to type 2 diabetes. J Endocrinol Invest 2020;43:451-9. [PMID: 31721085 DOI: 10.1007/s40618-019-01129-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
28 Uusitupa M, Khan TA, Viguiliouk E, Kahleova H, Rivellese AA, Hermansen K, Pfeiffer A, Thanopoulou A, Salas-Salvadó J, Schwab U, Sievenpiper JL. Prevention of Type 2 Diabetes by Lifestyle Changes: A Systematic Review and Meta-Analysis. Nutrients 2019;11:E2611. [PMID: 31683759 DOI: 10.3390/nu11112611] [Cited by in Crossref: 98] [Cited by in F6Publishing: 104] [Article Influence: 32.7] [Reference Citation Analysis]
29 Shen Y, Hou L, Liu H, Wang L, Leng J, Li W, Hu G. Racial differences of incident diabetes postpartum in women with a history of gestational diabetes. J Diabetes Complications 2019;33:107472. [PMID: 31653558 DOI: 10.1016/j.jdiacomp.2019.107472] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
30 Zhang H, Ni J, Yu C, Wu Y, Li J, Liu J, Tu J, Ning X, He Q, Wang J. Sex-Based Differences in Diabetes Prevalence and Risk Factors: A Population-Based Cross-Sectional Study Among Low-Income Adults in China. Front Endocrinol (Lausanne) 2019;10:658. [PMID: 31608013 DOI: 10.3389/fendo.2019.00658] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
31 Gruss SM, Nhim K, Gregg E, Bell M, Luman E, Albright A. Public Health Approaches to Type 2 Diabetes Prevention: the US National Diabetes Prevention Program and Beyond. Curr Diab Rep 2019;19:78. [PMID: 31385061 DOI: 10.1007/s11892-019-1200-z] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 17.7] [Reference Citation Analysis]
32 Aro A, Kauppinen A, Kivinen N, Selander T, Kinnunen K, Tuomilehto J, Keinänen-Kiukaanniemi S, Lindström J, Uusitupa M, Kaarniranta K. Life Style Intervention Improves Retinopathy Status-The Finnish Diabetes Prevention Study. Nutrients 2019;11:E1691. [PMID: 31340493 DOI: 10.3390/nu11071691] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
33 Nathan DM, Bennett PH, Crandall JP, Edelstein SL, Goldberg RB, Kahn SE, Knowler WC, Mather KJ, Mudaliar S, Orchard TJ, Temprosa M, White NH; Research Group. Does diabetes prevention translate into reduced long-term vascular complications of diabetes? Diabetologia 2019;62:1319-28. [PMID: 31270584 DOI: 10.1007/s00125-019-4928-8] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 9.7] [Reference Citation Analysis]
34 Dagogo-jack S. Prevention begets prevention — lessons from the Da Qing Study. Nat Rev Endocrinol 2019;15:442-3. [DOI: 10.1038/s41574-019-0227-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Yamagata K, Hoshino J, Sugiyama H, Hanafusa N, Shibagaki Y, Komatsu Y, Konta T, Fujii N, Kanda E, Sofue T, Ishizuka K, Kitagawa M, Kono K, Hinamoto N, Miyai T, Koike K, Toda S, Hasegawa J, Yamanouchi M, Yoshimura R, Ishii R, Goto S, Kawarazaki H, Takase K, Taki F, Matsumura M, Raita Y, Sakurai S, Shimizu T, Yamanoto S, Kawaguchi T, Oguchi H, Tsujita M, Yazawa M, Uchida A, Ando Y, Kaneko S, Matsunaga A, Harada T, Ito O, Kohzuki M. Clinical practice guideline for renal rehabilitation: systematic reviews and recommendations of exercise therapies in patients with kidney diseases. Ren Replace Ther 2019;5. [DOI: 10.1186/s41100-019-0209-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 13.3] [Reference Citation Analysis]
36 Bönhof GJ, Herder C, Strom A, Papanas N, Roden M, Ziegler D. Emerging Biomarkers, Tools, and Treatments for Diabetic Polyneuropathy. Endocr Rev 2019;40:153-92. [PMID: 30256929 DOI: 10.1210/er.2018-00107] [Cited by in Crossref: 96] [Cited by in F6Publishing: 101] [Article Influence: 32.0] [Reference Citation Analysis]
37 Gong Q, Zhang P, Wang J, Ma J, An Y, Chen Y, Zhang B, Feng X, Li H, Chen X, Cheng YJ, Gregg EW, Hu Y, Bennett PH, Li G; Da Qing Diabetes Prevention Study Group. Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study. Lancet Diabetes Endocrinol 2019;7:452-61. [PMID: 31036503 DOI: 10.1016/S2213-8587(19)30093-2] [Cited by in Crossref: 182] [Cited by in F6Publishing: 204] [Article Influence: 60.7] [Reference Citation Analysis]
38 Hui Y, Wang J, An Y, Gong Q, Li H, Zhang B, Shuai Y, Chen Y, Hu Y, Li G. Premature death and risk of cardiovascular disease in young-onset diabetes: a 23-year follow-up of the Da Qing Diabetes Study. Endocrine 2019;65:46-52. [PMID: 31001730 DOI: 10.1007/s12020-019-01928-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
39 Li X, Wang J, Shen X, An Y, Gong Q, Li H, Zhang B, Shuai Y, Chen Y, Hu Y, Li G. Higher blood pressure predicts diabetes and enhances long-term risk of cardiovascular disease events in individuals with impaired glucose tolerance: Twenty-three-year follow-up of the Daqing diabetes prevention study. J Diabetes. 2019;11:593-598. [PMID: 30556339 DOI: 10.1111/1753-0407.12887] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
40 Nylén ES, Kokkinos P. Physical Activity, Cardiorespiratory Fitness, and the Diabetes Spectrum. Cardiorespiratory Fitness in Cardiometabolic Diseases 2019. [DOI: 10.1007/978-3-030-04816-7_11] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
41 Lu B, Yin W, Ren X, Chen S. A Test on the Move: Cardiac CT in China as a Case Study. Contemporary Medical Imaging 2019. [DOI: 10.1007/978-1-60327-237-7_54] [Reference Citation Analysis]
42 Fagg J, Valabhji J. How do we identify people at high risk of Type 2 diabetes and help prevent the condition from developing? Diabet Med 2019;36:316-25. [PMID: 30466172 DOI: 10.1111/dme.13867] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
43 Rhee SY, Chon S, Ahn KJ, Woo JT; Korean Diabetes Prevention Study Investigators. Hospital-Based Korean Diabetes Prevention Study: A Prospective, Multi-Center, Randomized, Open-Label Controlled Study. Diabetes Metab J 2019;43:49-58. [PMID: 30398039 DOI: 10.4093/dmj.2018.0033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
44 Heng XP, Li XJ, Li L, Yang LQ, Wang ZT, Huang SP. Therapy to Obese Type 2 Diabetes Mellitus: How Far Will We Go Down the Wrong Road? Chin J Integr Med 2020;26:62-71. [PMID: 30328570 DOI: 10.1007/s11655-018-3053-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
45 Gray LJ, Willis A, Webb D, Davies MJ, Khunti K. Screening for Diabetes and Prediabetes. In: Bonora E, Defronzo RA, editors. Diabetes Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment. Cham: Springer International Publishing; 2018. pp. 369-400. [DOI: 10.1007/978-3-319-45015-5_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
46 Khunti K, Gavin JR, Boulton AJ, Blickstead R, Mcgill M, Ceriello A, Raz I, Sadikot S, Wood DA, Cos X, Kalra S, Das AK, Espinosa López C. The Berlin Declaration: A call to improve early actions related to type 2 diabetes. Why is primary care important? Primary Care Diabetes 2018;12:383-92. [DOI: 10.1016/j.pcd.2018.04.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
47 Rhodes EC, Chandrasekar EK, Patel SA, Narayan KMV, Joshua TV, Williams LB, Marion L, Ali MK. Cost-effectiveness of a faith-based lifestyle intervention for diabetes prevention among African Americans: A within-trial analysis. Diabetes Res ClinPract. 2018;146:85-92. [PMID: 30273708 DOI: 10.1016/j.diabres.2018.09.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
48 Wu Z, Jin T, Weng J. A thorough analysis of diabetes research in China from 1995 to 2015: current scenario and future scope. Sci China Life Sci 2019;62:46-62. [DOI: 10.1007/s11427-018-9377-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
49 Bowen ME, Schmittdiel JA, Kullgren JT, Ackermann RT, O'Brien MJ. Building Toward a Population-Based Approach to Diabetes Screening and Prevention for US Adults. Curr Diab Rep 2018;18:104. [PMID: 30229480 DOI: 10.1007/s11892-018-1090-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
50 Tong YZ, Tong NW, Teng WP, Mu YM, Zhao JJ, Shan ZY, Ning G; Chinese Society of Endocrinology. Consensus on the Prevention of Type 2 Diabetes in Chinese Adults. Chin Med J (Engl) 2017;130:600-6. [PMID: 28229993 DOI: 10.4103/0366-6999.200532] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
51 Tsao HY, Chan PY, Su EC. Predicting diabetic retinopathy and identifying interpretable biomedical features using machine learning algorithms. BMC Bioinformatics 2018;19:283. [PMID: 30367589 DOI: 10.1186/s12859-018-2277-0] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 11.3] [Reference Citation Analysis]
52 Glechner A, Keuchel L, Affengruber L, Titscher V, Sommer I, Matyas N, Wagner G, Kien C, Klerings I, Gartlehner G. Effects of lifestyle changes on adults with prediabetes: A systematic review and meta-analysis. Prim Care Diabetes 2018;12:393-408. [PMID: 30076075 DOI: 10.1016/j.pcd.2018.07.003] [Cited by in Crossref: 71] [Cited by in F6Publishing: 75] [Article Influence: 17.8] [Reference Citation Analysis]
53 Shen X, Zhang P, Wang J, An Y, Gregg EW, Zhang B, Li H, Gong Q, Chen Y, Shuai Y, Engelgau MM, Hu Y, Bennett PH, Li G. Influence of improvement or worsening of glucose tolerance on risk of stroke in persons with impaired glucose tolerance. Int J Stroke 2018;13:941-8. [PMID: 29956594 DOI: 10.1177/1747493018784432] [Reference Citation Analysis]
54 Andersson-Hall U, Gustavsson C, Pedersen A, Malmodin D, Joelsson L, Holmäng A. Higher Concentrations of BCAAs and 3-HIB Are Associated with Insulin Resistance in the Transition from Gestational Diabetes to Type 2 Diabetes. J Diabetes Res 2018;2018:4207067. [PMID: 29967793 DOI: 10.1155/2018/4207067] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
55 O'Brien MJ, Bullard KM, Zhang Y, Gregg EW, Carnethon MR, Kandula NR, Ackermann RT. Performance of the 2015 US Preventive Services Task Force Screening Criteria for Prediabetes and Undiagnosed Diabetes. J Gen Intern Med 2018;33:1100-8. [PMID: 29651678 DOI: 10.1007/s11606-018-4436-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
56 Sievenpiper JL, Chan CB, Dworatzek PD, Freeze C, Williams SL. Nutrition Therapy. Canadian Journal of Diabetes 2018;42:S64-79. [DOI: 10.1016/j.jcjd.2017.10.009] [Cited by in Crossref: 75] [Cited by in F6Publishing: 54] [Article Influence: 18.8] [Reference Citation Analysis]
57 Simmons RK, Borch-Johnsen K, Lauritzen T, Rutten GE, Sandbæk A, van den Donk M, Black JA, Tao L, Wilson EC, Davies MJ, Khunti K, Sharp SJ, Wareham NJ, Griffin SJ. A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study. Health Technol Assess 2016;20:1-86. [PMID: 27583404 DOI: 10.3310/hta20640] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
58 Knowler WC. Prevention of Type 2 Diabetes. Endocrinology 2018. [DOI: 10.1007/978-3-319-27317-4_16-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
59 Gray LJ, Willis A, Webb D, Davies MJ, Khunti K. Screening for Diabetes and Prediabetes. Endocrinology 2018. [DOI: 10.1007/978-3-319-27317-4_12-1] [Reference Citation Analysis]
60 Knowler WC. Prevention of Type 2 Diabetes. Endocrinology 2018. [DOI: 10.1007/978-3-319-45015-5_16] [Reference Citation Analysis]
61 Ali MK, Siegel KR, Chandrasekar E, Tandon N, Montoya PA, Mbanya JC, Chan J, Zhang P, Narayan KMV. Diabetes: An Update on the Pandemic and Potential Solutions. In: Prabhakaran D, Anand S, Gaziano TA, Mbanya J, Wu Y, Nugent R, editors. Disease Control Priorities, Third Edition (Volume 5): Cardiovascular, Respiratory, and Related Disorders. The World Bank; 2017. pp. 209-34. [DOI: 10.1596/978-1-4648-0518-9_ch12] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
62 Hemmingsen B, Gimenez-Perez G, Mauricio D, Roqué I Figuls M, Metzendorf MI, Richter B. Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus. Cochrane Database Syst Rev 2017;12:CD003054. [PMID: 29205264 DOI: 10.1002/14651858.CD003054.pub4] [Cited by in Crossref: 54] [Cited by in F6Publishing: 87] [Article Influence: 10.8] [Reference Citation Analysis]
63 Kandula NR, Moran MR, Tang JW, O'Brien MJ. Preventing Diabetes in Primary Care: Providers' Perspectives About Diagnosing and Treating Prediabetes. Clin Diabetes 2018;36:59-66. [PMID: 29382980 DOI: 10.2337/cd17-0049] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
64 Loprinzi PD, Edwards MK, Frith E. Review of the literature examining the association between physical activity and retinopathy. Phys Sportsmed 2018;46:123-8. [PMID: 29157070 DOI: 10.1080/00913847.2018.1407619] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
65 Cefalu WT. "Prediabetes": Are There Problems With This Label? No, We Need Heightened Awareness of This Condition! Diabetes Care 2016;39:1472-7. [PMID: 27457639 DOI: 10.2337/dc16-1143] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 5.4] [Reference Citation Analysis]
66 Dorcely B, Katz K, Jagannathan R, Chiang SS, Oluwadare B, Goldberg IJ, Bergman M. Novel biomarkers for prediabetes, diabetes, and associated complications. Diabetes Metab Syndr Obes 2017;10:345-61. [PMID: 28860833 DOI: 10.2147/DMSO.S100074] [Cited by in Crossref: 94] [Cited by in F6Publishing: 101] [Article Influence: 18.8] [Reference Citation Analysis]
67 Martin S. Nichtmedikamentöse Therapie bei Prädiabetes und Typ-2-Diabetes. Diabetologe 2017;13:322-330. [DOI: 10.1007/s11428-017-0239-1] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
68 Jackson SL, Staimez LR, Safo S, Long Q, Rhee MK, Cunningham SA, Olson DE, Tomolo AM, Ramakrishnan U, Narayan VKM, Phillips LS. Participation in a National Lifestyle Change Program is associated with improved diabetes Control outcomes. J Diabetes Complications 2017;31:1430-6. [PMID: 28673663 DOI: 10.1016/j.jdiacomp.2017.06.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
69 Martin S. Gesunder Lebensstil muss in jeder Krankheitsphase auf den Therapieplan! Info Diabetol 2017;11:34-40. [DOI: 10.1007/s15034-017-1091-5] [Reference Citation Analysis]
70 Garst J, L'Heveder R, Siminerio LM, Motala AA, Gabbay RA, Chaney D, Cavan D. Sustaining diabetes prevention and care interventions: A multiple case study of translational research projects. Diabetes Res Clin Pract 2017;130:67-76. [PMID: 28575728 DOI: 10.1016/j.diabres.2017.04.025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
71 Chen X, Wu Z, Chen Y, Wang X, Zhu J, Wang N, Jiang Q, Fu C. Risk score model of type 2 diabetes prediction for rural Chinese adults: the Rural Deqing Cohort Study. J Endocrinol Invest 2017;40:1115-23. [DOI: 10.1007/s40618-017-0680-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
72 Dimitriadis GK, Randeva HS, Miras AD. Microvascular complications after metabolic surgery. Lancet Diabetes Endocrinol 2017;5:240-1. [PMID: 28237789 DOI: 10.1016/S2213-8587(17)30042-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
73 Carlsson LMS, Sjöholm K, Karlsson C, Jacobson P, Andersson-Assarsson JC, Svensson PA, Larsson I, Hjorth S, Neovius M, Taube M, Carlsson B, Peltonen M. Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study. Lancet Diabetes Endocrinol 2017;5:271-9. [PMID: 28237791 DOI: 10.1016/S2213-8587(17)30061-X] [Cited by in Crossref: 85] [Cited by in F6Publishing: 92] [Article Influence: 17.0] [Reference Citation Analysis]
74 Teeuw WJ, Kosho MX, Poland DC, Gerdes VE, Loos BG. Periodontitis as a possible early sign of diabetes mellitus. BMJ Open Diabetes Res Care 2017;5:e000326. [PMID: 28316794 DOI: 10.1136/bmjdrc-2016-000326] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 8.6] [Reference Citation Analysis]
75 Glandt M, Bloomgarden Z. The Future of Diabetes. Principles of Diabetes Mellitus 2017. [DOI: 10.1007/978-3-319-18741-9_48] [Reference Citation Analysis]
76 Chan JCN, Chow EYK, Luk AO. Diabetes in China and the Western Pacific Region. Diabetes Mellitus in Developing Countries and Underserved Communities 2017. [DOI: 10.1007/978-3-319-41559-8_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
77 Skyler JS, Bakris GL, Bonifacio E, Darsow T, Eckel RH, Groop L, Groop PH, Handelsman Y, Insel RA, Mathieu C, McElvaine AT, Palmer JP, Pugliese A, Schatz DA, Sosenko JM, Wilding JP, Ratner RE. Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis. Diabetes 2017;66:241-55. [PMID: 27980006 DOI: 10.2337/db16-0806] [Cited by in Crossref: 312] [Cited by in F6Publishing: 329] [Article Influence: 52.0] [Reference Citation Analysis]
78 Zheng L, Wang Y, Hao S, Shin AY, Jin B, Ngo AD, Jackson-Browne MS, Feller DJ, Fu T, Zhang K, Zhou X, Zhu C, Dai D, Yu Y, Zheng G, Li YM, McElhinney DB, Culver DS, Alfreds ST, Stearns F, Sylvester KG, Widen E, Ling XB. Web-based Real-Time Case Finding for the Population Health Management of Patients With Diabetes Mellitus: A Prospective Validation of the Natural Language Processing-Based Algorithm With Statewide Electronic Medical Records. JMIR Med Inform 2016;4:e37. [PMID: 27836816 DOI: 10.2196/medinform.6328] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 6.8] [Reference Citation Analysis]
79 Yun JS, Lim TS, Cha SA, Ahn YB, Song KH, Choi JA, Kwon J, Jee D, Cho YK, Park YM, Ko SH. Clinical Course and Risk Factors of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus in Korea. Diabetes Metab J 2016;40:482-93. [PMID: 27766793 DOI: 10.4093/dmj.2016.40.6.482] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 5.2] [Reference Citation Analysis]
80 Edwards CM, Cusi K. Prediabetes: A Worldwide Epidemic. Endocrinol Metab Clin North Am 2016;45:751-64. [PMID: 27823603 DOI: 10.1016/j.ecl.2016.06.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 6.5] [Reference Citation Analysis]
81 Flood D, Mux S, Martinez B, García P, Douglas K, Goldberg V, Lopez W, Rohloff P. Implementation and Outcomes of a Comprehensive Type 2 Diabetes Program in Rural Guatemala. PLoS One 2016;11:e0161152. [PMID: 27583362 DOI: 10.1371/journal.pone.0161152] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
82 Uusitupa M. Lifestyle changes and cardiovascular risk reduction in diabetes. Lancet Diabetes Endocrinol. 2016;4:877-878. [PMID: 27595919 DOI: 10.1016/s2213-8587(16)30185-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
83 Calabek B, Callaghan B, Feldman EL. Therapy for diabetic neuropathy: an overview. Handb Clin Neurol 2014;126:317-33. [PMID: 25410231 DOI: 10.1016/B978-0-444-53480-4.00022-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
84 Gong Q, Zhang P, Wang J, An Y, Gregg EW, Li H, Zhang B, Shuai Y, Yang W, Chen Y, Liu S, Engelgau MM, Hu Y, Bennett PH, Li G. Changes in Mortality in People With IGT Before and After the Onset of Diabetes During the 23-Year Follow-up of the Da Qing Diabetes Prevention Study. Diabetes Care 2016;39:1550-5. [PMID: 27411697 DOI: 10.2337/dc16-0429] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
85 Guclu M, Ali A, Eroglu DU, Büyükuysal SO, Cander S, Ocak N. Serum Levels of sRAGE Are Associated with Body Measurements, but Not Glycemic Parameters in Patients with Prediabetes. Metabolic Syndrome and Related Disorders 2016;14:33-9. [DOI: 10.1089/met.2015.0078] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
86 Alouki K, Delisle H, Bermúdez-Tamayo C, Johri M. Lifestyle Interventions to Prevent Type 2 Diabetes: A Systematic Review of Economic Evaluation Studies. J Diabetes Res 2016;2016:2159890. [PMID: 26885527 DOI: 10.1155/2016/2159890] [Cited by in Crossref: 30] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
87 Glandt M, Bloomgarden Z. The Future of Diabetes. Principles of Diabetes Mellitus 2016. [DOI: 10.1007/978-3-319-20797-1_48-1] [Reference Citation Analysis]
88 Wahlqvist ML. Food structure is critical for optimal health. Food Funct 2016;7:1245-50. [DOI: 10.1039/c5fo01285f] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
89 Balk EM, Earley A, Raman G, Avendano EA, Pittas AG, Remington PL. Combined Diet and Physical Activity Promotion Programs to Prevent Type 2 Diabetes Among Persons at Increased Risk: A Systematic Review for the Community Preventive Services Task Force. Ann Intern Med. 2015;163:437-451. [PMID: 26167912 DOI: 10.7326/m15-0452] [Cited by in Crossref: 187] [Cited by in F6Publishing: 206] [Article Influence: 26.7] [Reference Citation Analysis]
90 Lip S, Jeemon P, McCallum L, Dominiczak AF, McInnes GT, Padmanabhan S. Contrasting mortality risks among subgroups of treated hypertensive patients developing new-onset diabetes. Eur Heart J 2016;37:968-74. [PMID: 26508167 DOI: 10.1093/eurheartj/ehv557] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
91 Checkley W, Ghannem H, Irazola V, Kimaiyo S, Levitt NS, Miranda JJ, Niessen L, Prabhakaran D, Rabadán-Diehl C, Ramirez-Zea M, Rubinstein A, Sigamani A, Smith R, Tandon N, Wu Y, Xavier D, Yan LL; GRAND South Network, UnitedHealth Group/National Heart, Lung, and Blood Institute Centers of Excellence. Management of NCD in low- and middle-income countries. Glob Heart 2014;9:431-43. [PMID: 25592798 DOI: 10.1016/j.gheart.2014.11.003] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 10.1] [Reference Citation Analysis]
92 Popp Switzer M, Elhanafi S, San Juan ZT. Change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance. Curr Cardiol Rep 2015;17:562. [PMID: 25638410 DOI: 10.1007/s11886-015-0562-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
93 Martin S. Was Lebensstilintervention bei Typ-2-Diabetes bringt. Info Diabetol 2015;9:44-47. [DOI: 10.1007/s15034-015-0637-7] [Reference Citation Analysis]
94 Bril V. Neuromuscular complications of diabetes mellitus. Continuum (Minneap Minn) 2014;20:531-44. [PMID: 24893232 DOI: 10.1212/01.CON.0000450964.30710.a0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
95 Aroda VR, Getaneh A. Guiding diabetes screening and prevention: rationale, recommendations and remaining challenges. Expert Rev Endocrinol Metab 2015;10:381-98. [PMID: 30293496 DOI: 10.1586/17446651.2015.1054280] [Reference Citation Analysis]
96 Mata-cases M, Artola S, Escalada J, Ezkurra-loyola P, Ferrer-garcía J, Fornos J, Girbés J, Rica I. Consenso sobre la detección y el manejo de la prediabetes. Grupo de Trabajo de Consensos y Guías Clínicas de la Sociedad Española de Diabetes. SEMERGEN - Medicina de Familia 2015;41:266-78. [DOI: 10.1016/j.semerg.2014.12.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
97 Sood HS, Maruthappu M, Valabhji J. The National Diabetes Prevention Programme: a pathway for prevention and wellbeing. Br J Gen Pract 2015;65:336-7. [PMID: 26120107 DOI: 10.3399/bjgp15X685537] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
98 Phillips LS, Ratner RE, Buse JB, Kahn SE. We can change the natural history of type 2 diabetes. Diabetes Care 2014;37:2668-76. [PMID: 25249668 DOI: 10.2337/dc14-0817] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 8.4] [Reference Citation Analysis]
99 Staimez LR, Weber MB, Gregg EW. The role of lifestyle change for prevention of cardiovascular disease in diabetes. Curr Atheroscler Rep 2014;16:460. [PMID: 25363453 DOI: 10.1007/s11883-014-0460-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
100 Galtier F, Bringer J. Effets de la perte de poids sur la morbidité et la mortalité cardiovasculaires des diabétiques de type 2. Bulletin de l'Académie Nationale de Médecine 2015;199:823-833. [DOI: 10.1016/s0001-4079(19)30885-4] [Reference Citation Analysis]
101 Ghody P, Shikha D, Karam J, Bahtiyar G. Identifying prediabetes – Is it beneficial in the long run? Maturitas 2015;81:282-6. [DOI: 10.1016/j.maturitas.2015.03.022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
102 Martin S. Pathophysiologie und Prävention des Typ-2-Diabetes. Diabetologe 2015;11:270-278. [DOI: 10.1007/s11428-015-1340-y] [Reference Citation Analysis]
103 Tuso P. Prediabetes and lifestyle modification: time to prevent a preventable disease. Perm J 2014;18:88-93. [PMID: 25102521 DOI: 10.7812/TPP/14-002] [Cited by in Crossref: 108] [Cited by in F6Publishing: 116] [Article Influence: 15.4] [Reference Citation Analysis]
104 Mata-cases M, Artola S, Escalada J, Ezkurra-loyola P, Ferrer-garcía JC, Fornos JA, Girbés J, Rica I. Consenso sobre la detección y el manejo de la prediabetes. Grupo de Trabajo de Consensos y Guías Clínicas de la Sociedad Española de Diabetes. Avances en Diabetología 2015;31:89-101. [DOI: 10.1016/j.avdiab.2014.10.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
105 An Y, Zhang P, Wang J, Gong Q, Gregg EW, Yang W, Li H, Zhang B, Shuai Y, Chen Y, Engelgau MM, Cheng Y, Hu Y, Bennett PH, Li G. Cardiovascular and All-Cause Mortality Over a 23-Year Period Among Chinese With Newly Diagnosed Diabetes in the Da Qing IGT and Diabetes Study. Diabetes Care 2015;38:1365-71. [PMID: 25887356 DOI: 10.2337/dc14-2498] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 6.6] [Reference Citation Analysis]
106 Azmi S, Ferdousi M, Petropoulos IN, Ponirakis G, Alam U, Fadavi H, Asghar O, Marshall A, Atkinson AJ, Jones W. Corneal Confocal Microscopy Identifies Small-Fiber Neuropathy in Subjects With Impaired Glucose Tolerance Who Develop Type 2 Diabetes. Diabetes Care. 2015;38:1502-1508. [PMID: 25877814 DOI: 10.2337/dc14-2733] [Cited by in Crossref: 102] [Cited by in F6Publishing: 106] [Article Influence: 14.6] [Reference Citation Analysis]
107 Bansal N. Prediabetes diagnosis and treatment: A review. World J Diabetes 2015; 6(2): 296-303 [PMID: 25789110 DOI: 10.4239/wjd.v6.i2.296] [Cited by in CrossRef: 243] [Cited by in F6Publishing: 257] [Article Influence: 34.7] [Reference Citation Analysis]
108 Mata-Cases M, Artola S, Escalada J, Ezkurra-Loyola P, Ferrer-García JC, Fornos JA, Girbés J, Rica I; Grupo de Trabajo de Consensos y Guías Clínicas de la Sociedad Española de Diabetes. [Consensus on the detection and management of prediabetes. Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society]. Aten Primaria 2015;47:456-68. [PMID: 25735589 DOI: 10.1016/j.aprim.2014.12.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
109 Mata-cases M, Artola S, Escalada J, Ezkurra-loyola P, Ferrer-garcía J, Fornos J, Girbés J, Rica I. Consensus on the detection and management of prediabetes. Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society. Revista Clínica Española (English Edition) 2015;215:117-29. [DOI: 10.1016/j.rceng.2014.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
110 Mata-cases M, Artola S, Escalada J, Ezkurra-loyola P, Ferrer-garcía J, Fornos J, Girbés J, Rica I. Consenso sobre la detección y el manejo de la prediabetes. Grupo de Trabajo de Consensos y Guías Clínicas de la Sociedad Española de Diabetes. Revista Clínica Española 2015;215:117-29. [DOI: 10.1016/j.rce.2014.10.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
111 Mata-cases M, Artola S, Escalada J, Ezkurra-loyola P, Ferrer-garcía J, Fornos J, Girbés J, Rica I. Consenso sobre la detección y el manejo de la prediabetes. Grupo de Trabajo de Consensos y Guías Clínicas de la Sociedad Española de Diabetes. Endocrinología y Nutrición 2015;62:e23-36. [DOI: 10.1016/j.endonu.2014.10.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
112 Wang D, Li X, Zhang L, Zhou L, Zhang K. WITHDRAWN: Effects of motivational interviewing on lifestyle modification and diabetes prevention in adults with pre-diabetes. Diabetes Research and Clinical Practice 2015. [DOI: 10.1016/j.diabres.2015.01.042] [Reference Citation Analysis]
113 Olson DE, Zhu M, Long Q, Barb D, Haw JS, Rhee MK, Mohan AV, Watson-Williams PI, Jackson SL, Tomolo AM, Wilson PW, Narayan KM, Lipscomb J, Phillips LS. Increased cardiovascular disease, resource use, and costs before the clinical diagnosis of diabetes in veterans in the southeastern U.S. J Gen Intern Med 2015;30:749-57. [PMID: 25608739 DOI: 10.1007/s11606-014-3075-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
114 Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, Huikuri H. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary. Diab Vasc Dis Res. 2014;11:133-173. [PMID: 24800783 DOI: 10.1177/1479164114525548] [Cited by in Crossref: 131] [Cited by in F6Publishing: 146] [Article Influence: 18.7] [Reference Citation Analysis]
115 Gess B, Young P. Primäre Neuropathien und Polyneuropathien. Therapie und Prävention Durch Sport, Band 2 2015. [DOI: 10.1016/b978-3-437-24265-6.00011-1] [Reference Citation Analysis]
116 Ryan AS. Exercise and Hypertension in the Framework of the Metabolic Syndrome. Molecular and Translational Medicine 2015. [DOI: 10.1007/978-3-319-17076-3_12] [Reference Citation Analysis]
117 Dunkler D, Kohl M, Heinze G, Teo KK, Rosengren A, Pogue J, Gao P, Gerstein H, Yusuf S, Oberbauer R, Mann JF; ONTARGET Investigators. Modifiable lifestyle and social factors affect chronic kidney disease in high-risk individuals with type 2 diabetes mellitus. Kidney Int 2015;87:784-91. [PMID: 25493953 DOI: 10.1038/ki.2014.370] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 7.6] [Reference Citation Analysis]
118 Glechner A, Harreiter J, Gartlehner G, Rohleder S, Kautzky A, Tuomilehto J, Van Noord M, Kaminski-hartenthaler A, Kautzky-willer A. Sex-specific differences in diabetes prevention: a systematic review and meta-analysis. Diabetologia 2015;58:242-54. [DOI: 10.1007/s00125-014-3439-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 4.1] [Reference Citation Analysis]
119 Bethel MA, Xu W, Theodorakis MJ. Pharmacological interventions for preventing or delaying onset of type 2 diabetes mellitus. Diabetes Obes Metab 2015;17:231-44. [PMID: 25312701 DOI: 10.1111/dom.12401] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
120 Anjana RM, Ranjani H, Unnikrishnan R, Weber MB, Mohan V, Narayan KM. Exercise patterns and behaviour in Asian Indians: data from the baseline survey of the Diabetes Community Lifestyle Improvement Program (D-CLIP). Diabetes Res Clin Pract 2015;107:77-84. [PMID: 25458336 DOI: 10.1016/j.diabres.2014.09.053] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
121 Bloomgarden ZT. Is glycemic control a quinidine-like intervention? 控制血糖与使用奎尼丁治疗一样吗?. Journal of Diabetes 2014;6:387-388. [DOI: 10.1111/1753-0407.12170] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
122 Yudkin JS, Montori VM. The epidemic of pre-diabetes: the medicine and the politics. BMJ 2014;349:g4485. [PMID: 25028385 DOI: 10.1136/bmj.g4485] [Cited by in Crossref: 131] [Cited by in F6Publishing: 144] [Article Influence: 16.4] [Reference Citation Analysis]
123 Li G, Zhang P, Gregg EW, Engelgau MM, Bennett PH. Authors' reply. Lancet Diabetes Endocrinol 2014;2:540. [PMID: 24999258 DOI: 10.1016/S2213-8587(14)70131-7] [Reference Citation Analysis]
124 Holman RR, Bethel MA, Chan JC, Chiasson JL, Doran Z, Ge J, Gerstein H, Huo Y, McMurray JJ, Ryden L, Liyanage W, Schröder S, Tendera M, Theodorakis MJ, Tuomilehto J, Yang W, Hu D, Pan C; ACE Study Group. Rationale for and design of the Acarbose Cardiovascular Evaluation (ACE) trial. Am Heart J 2014;168:23-9.e2. [PMID: 24952856 DOI: 10.1016/j.ahj.2014.03.021] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 4.5] [Reference Citation Analysis]
125 Li G, Zhang P, Wang J, An Y, Gong Q, Gregg EW, Yang W, Zhang B, Shuai Y, Hong J, Engelgau MM, Li H, Roglic G, Hu Y, Bennett PH. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. The Lancet Diabetes & Endocrinology 2014;2:474-80. [DOI: 10.1016/s2213-8587(14)70057-9] [Cited by in Crossref: 418] [Cited by in F6Publishing: 439] [Article Influence: 52.3] [Reference Citation Analysis]
126 Wareham NJ. The long-term benefits of lifestyle interventions for prevention of diabetes. Lancet Diabetes Endocrinol 2014;2:441-2. [PMID: 24731680 DOI: 10.1016/S2213-8587(14)70074-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
127 Long GH, Cooper AJM, Wareham NJ, Griffin SJ, Simmons RK. Healthy Behavior Change and Cardiovascular Outcomes in Newly Diagnosed Type 2 Diabetic Patients: A Cohort Analysis of the ADDITION-Cambridge Study. Diabetes Care. 2014;37:1712-1720. [PMID: 24658389 DOI: 10.2337/dc13-1731] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
128 Wilding JP. The importance of weight management in type 2 diabetes mellitus. Int J Clin Pract 2014;68:682-91. [PMID: 24548654 DOI: 10.1111/ijcp.12384] [Cited by in Crossref: 142] [Cited by in F6Publishing: 148] [Article Influence: 17.8] [Reference Citation Analysis]
129 Gill JM, Celis-morales CA, Ghouri N. Physical activity, ethnicity and cardio-metabolic health: Does one size fit all? Atherosclerosis 2014;232:319-33. [DOI: 10.1016/j.atherosclerosis.2013.11.039] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
130 Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes H, Huikuri H, Marre M, Marx N, Mellbin L, Ostergren J, Patrono C, Seferovic P, Sousa Uva M, Taskinen M, Tendera M, Tuomilehto J, Valensi P, Luis Zamorano J, Luis Zamorano J, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol Ç, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Anton Sirnes P, Luis Tamargo J, Tendera M, Torbicki A, Wijns W, Windecker S, De Backer G, Anton Sirnes P, Alegria Ezquerra E, Avogaro A, Badimon L, Baranova E, Baumgartner H, Betteridge J, Ceriello A, Fagard R, Funck-brentano C, Gulba DC, Hasdai D, Hoes AW, Kjekshus JK, Knuuti J, Kolh P, Lev E, Mueller C, Neyses L, Nilsson PM, Perk J, Ponikowski P, Reiner Ž, Sattar N, Schächinger V, Scheen A, Schirmer H, Strömberg A, Sudzhaeva S, Luis Tamargo J, Viigimaa M, Vlachopoulos C, Xuereb RG; Grupo de Trabajo de la Sociedad Europea de Cardiología sobre diagnóstico y tratamiento de la cardiopatía isquémica estable, Grupo de Trabajo de la Sociedad Europea de Cardiología sobre diagnóstico y tratamiento de la cardiopatía isquémica estable, Grupo de Trabajo de la Sociedad Europea de Cardiología sobre diagnóstico y tratamiento de la cardiopatía isquémica estable. Guía de práctica clínica de la ESC sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes. Revista Española de Cardiología 2014;67:136.e1-136.e56. [DOI: 10.1016/j.recesp.2013.10.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
131 Ferrannini E. Definition of intervention points in prediabetes. Lancet Diabetes Endocrinol 2014;2:667-75. [PMID: 24731662 DOI: 10.1016/S2213-8587(13)70175-X] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 5.5] [Reference Citation Analysis]
132 Nielsen KK, Kapur A, Damm P, de Courten M, Bygbjerg IC. From screening to postpartum follow-up - the determinants and barriers for gestational diabetes mellitus (GDM) services, a systematic review. BMC Pregnancy Childbirth 2014;14:41. [PMID: 24450389 DOI: 10.1186/1471-2393-14-41] [Cited by in Crossref: 140] [Cited by in F6Publishing: 148] [Article Influence: 17.5] [Reference Citation Analysis]
133 Kahn SE, Cooper ME, Del Prato S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet. 2014;383:1068-1083. [PMID: 24315620 DOI: 10.1016/s0140-6736(13)62154-6] [Cited by in Crossref: 942] [Cited by in F6Publishing: 990] [Article Influence: 104.7] [Reference Citation Analysis]
134 Chan JC, Cho NH, Tajima N, Shaw J. Diabetes in the Western Pacific Region--past, present and future. Diabetes Res Clin Pract 2014;103:244-55. [PMID: 24418400 DOI: 10.1016/j.diabres.2013.11.012] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 7.3] [Reference Citation Analysis]
135 Cooper ME, Rebuck AS. Type 2 diabetes in Asia: like chronic obstructive pulmonary disease, a threat to human health and wellbeing. J Diabetes 2014;6:120-2. [PMID: 24134129 DOI: 10.1111/1753-0407.12097] [Reference Citation Analysis]
136 Ransom T, Goldenberg R, Mikalachki A, Prebtani AP, Punthakee Z. Réduction du risque de diabète. Canadian Journal of Diabetes 2013;37:S377-S380. [DOI: 10.1016/j.jcjd.2013.07.033] [Reference Citation Analysis]
137 Dworatzek PD, Arcudi K, Gougeon R, Husein N, Sievenpiper JL, Williams SL. Thérapie nutritionnelle. Canadian Journal of Diabetes 2013;37:S409-21. [DOI: 10.1016/j.jcjd.2013.07.048] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
138 Chandra S, Singh AK, Singh M, Das P, Singh S, Pandey HP, Singh RG. Prolonged elevated postprandial sugar augments severity in kidney disease: a north Indian hospital-based study. Ren Fail 2014;36:50-4. [PMID: 24059749 DOI: 10.3109/0886022X.2013.832862] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
139 Gregg EW, Boyle JP, Thompson TJ, Barker LE, Albright AL, Williamson DF. Modeling the impact of prevention policies on future diabetes prevalence in the United States: 2010-2030. Popul Health Metr 2013;11:18. [PMID: 24047329 DOI: 10.1186/1478-7954-11-18] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
140 Albright AL, Gregg EW. Preventing type 2 diabetes in communities across the U.S.: the National Diabetes Prevention Program. Am J Prev Med 2013;44:S346-51. [PMID: 23498297 DOI: 10.1016/j.amepre.2012.12.009] [Cited by in Crossref: 174] [Cited by in F6Publishing: 183] [Article Influence: 19.3] [Reference Citation Analysis]
141 Lalla E, Cheng B, Kunzel C, Burkett S, Lamster I. Dental Findings and Identification of Undiagnosed Hyperglycemia. J Dent Res 2013;92:888-92. [DOI: 10.1177/0022034513502791] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 5.7] [Reference Citation Analysis]
142 Feng R, Li K, Cheng J, Xie S, Chai J, Wei P, Wang D. Toward integrated and sustainable prevention against diabetes in rural China: study rationale and protocol of eCROPS. BMC Endocr Disord 2013;13:28. [PMID: 23919331 DOI: 10.1186/1472-6823-13-28] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
143 Liu X, Li C, Gong H, Cui Z, Fan L, Yu W, Zhang C, Ma J. An economic evaluation for prevention of diabetes mellitus in a developing country: a modelling study. BMC Public Health 2013;13:729. [PMID: 23919839 DOI: 10.1186/1471-2458-13-729] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
144 Waldeyer R, Brinks R, Rathmann W, Giani G, Icks A. Projection of the burden of type 2 diabetes mellitus in Germany: a demographic modelling approach to estimate the direct medical excess costs from 2010 to 2040. Diabet Med 2013;30:999-1008. [PMID: 23506452 DOI: 10.1111/dme.12177] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
145 Chan JC. Risk-benefit analysis of use of statins for primary prevention of cardiovascular disease in subjects without diabetes. J Diabetes Investig 2013;4:344-6. [PMID: 24843676 DOI: 10.1111/jdi.12076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
146 Dworatzek PD, Arcudi K, Gougeon R, Husein N, Sievenpiper JL, Williams SL. Nutrition therapy. Can J Diabetes. 2013;37 Suppl 1:S45-S55. [PMID: 24070963 DOI: 10.1016/j.jcjd.2013.01.019] [Cited by in Crossref: 97] [Cited by in F6Publishing: 106] [Article Influence: 10.8] [Reference Citation Analysis]
147 Ransom T, Goldenberg R, Mikalachki A, Prebtani AP, Punthakee Z; Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Reducing the risk of developing diabetes. Can J Diabetes 2013;37 Suppl 1:S16-9. [PMID: 24070941 DOI: 10.1016/j.jcjd.2013.01.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
148 Gao Y, Zhou H, Zhao H, Feng X, Feng J, Li Y, Zhang H, Lu H, Qian Q, Yu X, Zhang N, Yu J, Ni Q, Pan M. Clinical Research of Traditional Chinese Medical Intervention on Impaired Glucose Tolerance. Am J Chin Med 2013;41:21-32. [DOI: 10.1142/s0192415x1350002x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
149 Mares JA, Millen AE, Meyers KJ. Diet and Supplements in the Prevention and Treatment of Eye Diseases. Nutrition in the Prevention and Treatment of Disease 2013. [DOI: 10.1016/b978-0-12-391884-0.00019-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
150 Gess B, Young P. Primäre Neuropathien und Polyneuropathien. Prävention und Therapie neurologischer und psychischer Krankheiten durch Sport 2013. [DOI: 10.1016/b978-3-437-31610-4.00016-3] [Reference Citation Analysis]
151 Teoh H, Lau DC, Camelon KM, Gilbert RE, Harris SB, Mcfarlane PA, Rabasa-lhoret R, Ur E, Leiter LA. Assessment and Treatment of Cardiometabolic Risk in Adults at Risk for or with Type 2 Diabetes Mellitus. Canadian Journal of Diabetes 2012;36:320-6. [DOI: 10.1016/j.jcjd.2012.08.009] [Reference Citation Analysis]
152 Rydén L, Mellbin L. Glucose perturbations and cardiovascular risk: challenges and opportunities. Diab Vasc Dis Res 2012;9:170-6. [PMID: 22752941 DOI: 10.1177/1479164112451581] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
153 Yang W, Zhao W, Xiao J, Li R, Zhang P, Kissimova-Skarbek K, Schneider E, Jia W, Ji L, Guo X, Shan Z, Liu J, Tian H, Chen L, Zhou Z, Ji Q, Ge J, Chen G, Brown J. Medical care and payment for diabetes in China: enormous threat and great opportunity. PLoS One 2012;7:e39513. [PMID: 23049727 DOI: 10.1371/journal.pone.0039513] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 5.3] [Reference Citation Analysis]
154 Phillips LS, Olson DE. Diabetes: normal glucose levels should be the goal. Nat Rev Endocrinol 2012;8:510-2. [PMID: 22847240 DOI: 10.1038/nrendo.2012.139] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
155 Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379:2279-2290. [PMID: 22683128 DOI: 10.1016/s0140-6736(12)60283-9] [Cited by in Crossref: 1388] [Cited by in F6Publishing: 1478] [Article Influence: 138.8] [Reference Citation Analysis]
156 Narayan KM, Echouffo-Tcheugui JB, Mohan V, Ali MK. Analysis & commentary: Global prevention and control of type 2 diabetes will require paradigm shifts in policies within and among countries. Health Aff (Millwood) 2012;31:84-92. [PMID: 22232098 DOI: 10.1377/hlthaff.2011.1040] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
157 Papanas N, Ziegler D. Prediabetic Neuropathy: Does It Exist? Curr Diab Rep 2012;12:376-83. [DOI: 10.1007/s11892-012-0278-3] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
158 Lyons TJ, Basu A. Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers. Transl Res. 2012;159:303-312. [PMID: 22424433 DOI: 10.1016/j.trsl.2012.01.009] [Cited by in Crossref: 125] [Cited by in F6Publishing: 137] [Article Influence: 12.5] [Reference Citation Analysis]
159 Kahn R. Reducing The Impact Of Diabetes: Is Prevention Feasible Today, Or Should We Aim For Better Treatment? Health Affairs 2012;31:76-83. [DOI: 10.1377/hlthaff.2011.1075] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
160 Glandt M, Bloomgarden Z. Da Qing, Finnish DPP, Tripod, and Dream: Lifestyle and Thiazolidinediones in the Prevention of Diabetes. Prevention of Type 2 Diabetes 2012. [DOI: 10.1007/978-1-4614-3314-9_11] [Reference Citation Analysis]
161 Vinik AI, Nevoret M. Neuropathy in Prediabetes and the Metabolic Syndrome. Prevention of Type 2 Diabetes 2012. [DOI: 10.1007/978-1-4614-3314-9_8] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
162 Ritz E, Zeng X. Diabetic nephropathy - Epidemiology in Asia and the current state of treatment. Indian J Nephrol 2011;21:75-84. [PMID: 21769168 DOI: 10.4103/0971-4065.82122] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
163 Papanas N, Vinik AI, Ziegler D. Neuropathy in prediabetes: does the clock start ticking early? Nat Rev Endocrinol. 2011;7:682-690. [PMID: 21750507 DOI: 10.1038/nrendo.2011.113] [Cited by in Crossref: 142] [Cited by in F6Publishing: 148] [Article Influence: 12.9] [Reference Citation Analysis]
164 Echouffo-Tcheugui JB, Ali MK, Griffin SJ, Narayan KM. Screening for type 2 diabetes and dysglycemia. Epidemiol Rev 2011;33:63-87. [PMID: 21624961 DOI: 10.1093/epirev/mxq020] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 4.8] [Reference Citation Analysis]